You are here: Home » News-CM » Companies » Results
Business Standard

Bafna Pharmaceuticals standalone net profit declines 99.57% in the December 2018 quarter

Capital Market 

Sales rise 20.35% to Rs 13.07 crore

Net profit of Bafna Pharmaceuticals declined 99.57% to Rs 0.12 crore in the quarter ended December 2018 as against Rs 28.09 crore during the previous quarter ended December 2017. Sales rose 20.35% to Rs 13.07 crore in the quarter ended December 2018 as against Rs 10.86 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales13.0710.86 20 OPM %8.955.06 -PBDT1.0229.08 -96 PBT0.1228.09 -100 NP0.1228.09 -100

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, February 09 2019. 16:54 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU